HCPCS Level IIdrugActive
J0219
Inj aval alfa-nqpt 4mg
BETOS: O1E
Effective: 2022-04-01
Description
Injection, avalglucosidase alfa-ngpt, 4 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Nexviazyme
Manufacturer
Genzyme Corporation
HCPCS Dosage
4 MG
Billing Units
25.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.